ES2181711T3 - Derivados amida como ligandos 5-ht 1a. - Google Patents

Derivados amida como ligandos 5-ht 1a.

Info

Publication number
ES2181711T3
ES2181711T3 ES94908456T ES94908456T ES2181711T3 ES 2181711 T3 ES2181711 T3 ES 2181711T3 ES 94908456 T ES94908456 T ES 94908456T ES 94908456 T ES94908456 T ES 94908456T ES 2181711 T3 ES2181711 T3 ES 2181711T3
Authority
ES
Spain
Prior art keywords
sup
sub
ligandos
och
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94908456T
Other languages
English (en)
Inventor
Ian Anthony Cliffe
Anderson Decourtney Ifill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Application granted granted Critical
Publication of ES2181711T3 publication Critical patent/ES2181711T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE PRESENTAN DERIVADOS DEL AMIDO DE LA FORMULA (I) EN LA QUE R{SUP, 1} ES UN RADICAL DE HETEROARIL MONO O BICICLICO, R{SUP, 2} ES CICLOALQUIL, R{SUP, 3}, R{SUP, 3''} Y R{SUP, 4} REPRESENTAN CADA UNA HIDROGENO O ALQUIL INFERIOR, Y R{SUP, 5} ES UN GRUPO DE LA FORMULA (A) O (B) O (C): R{SUP, 8}-CH{SUB, 2}-CH{SUB, 2} O (D) O (E): R{SUP, 9}OCH{SUB, 2}CHOHCH{SUB, 2}- O (F): R{SUP, 9}OCH{SUB, 2}CH{SUB, 2}-; TAMBIEN SE PRESENTAN SUS SALES FARMACOLOGICAMENTE ACEPTABLES QUE SON AGENTES DE UNION DEL 5HT{SUB, 1A} Y QUE PUEDEN UTILIZARSE, POR EJEMPLO, COMO ANSIOLITICOS.
ES94908456T 1993-03-19 1994-03-09 Derivados amida como ligandos 5-ht 1a. Expired - Lifetime ES2181711T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939305672A GB9305672D0 (en) 1993-03-19 1993-03-19 Amide derivatives

Publications (1)

Publication Number Publication Date
ES2181711T3 true ES2181711T3 (es) 2003-03-01

Family

ID=10732342

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94908456T Expired - Lifetime ES2181711T3 (es) 1993-03-19 1994-03-09 Derivados amida como ligandos 5-ht 1a.

Country Status (13)

Country Link
US (1) US5629323A (es)
EP (1) EP0689534B1 (es)
JP (1) JPH08507779A (es)
AT (1) ATE225335T1 (es)
AU (1) AU6149094A (es)
DE (1) DE69431471T2 (es)
DK (1) DK0689534T3 (es)
ES (1) ES2181711T3 (es)
GB (1) GB9305672D0 (es)
PH (1) PH31589A (es)
PT (1) PT689534E (es)
WO (1) WO1994021611A1 (es)
ZA (1) ZA941739B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541179A (en) * 1995-05-02 1996-07-30 American Home Products Corporation Tropon-2-one piperazine carboxamides as serotonergic agents
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
US6906069B1 (en) 1999-01-08 2005-06-14 Amgen Inc. LXR modulators
EP1035115B1 (en) 1999-02-24 2004-09-29 F. Hoffmann-La Roche Ag 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
AU2000235960A1 (en) * 2000-02-14 2001-08-27 Tularik, Inc. Lxr modulators
US6673543B2 (en) 2000-04-05 2004-01-06 Tularik, Inc. Solid phase synthesis of LXR ligands
JP4434745B2 (ja) 2002-01-30 2010-03-17 アムジェン インコーポレイテッド 複素環式アリールスルホンアミドベンジル化合物
US7288658B2 (en) 2003-07-15 2007-10-30 Hoffmann-La Roche Inc. Process for preparation of pyridine derivatives
PT1928427E (pt) 2005-09-23 2010-03-01 Hoffmann La Roche Nova forma galénica
CN106243088B (zh) 2015-06-03 2019-01-04 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241161A1 (es) * 1984-07-30 1991-12-30 Merrelll Dow Pharmaceuticals I "procedimiento para la preparacion de derivados n-aminoalquilen sustituidos de la glutarimida"
EP0367888A1 (en) * 1988-11-08 1990-05-16 ISTITUTO LUSO FARMACO D'ITALIA S.p.A. 2,2-Disubstituted 2,3-dihydro-1,4-benzodioxin derivatives having hypotensive activity
GB9021535D0 (en) * 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives

Also Published As

Publication number Publication date
PT689534E (pt) 2003-01-31
WO1994021611A1 (en) 1994-09-29
AU6149094A (en) 1994-10-11
EP0689534A1 (en) 1996-01-03
EP0689534B1 (en) 2002-10-02
GB9305672D0 (en) 1993-05-05
DE69431471D1 (de) 2002-11-07
ZA941739B (en) 1995-09-11
US5629323A (en) 1997-05-13
JPH08507779A (ja) 1996-08-20
ATE225335T1 (de) 2002-10-15
DK0689534T3 (da) 2003-02-03
DE69431471T2 (de) 2003-07-10
PH31589A (en) 1998-11-03

Similar Documents

Publication Publication Date Title
NO981944L (no) Lipopolyaminer som transfeksjonsmidler samt farmas÷ytisk anvendelse derav
ES2181711T3 (es) Derivados amida como ligandos 5-ht 1a.
TR200102800T2 (tr) Yeni bileşikler.
DE3575130D1 (de) Antiinflammatorische 1,n-diarylpyrazol-3-amine, deren zusammensetzungen und verfahren zu deren herstellung.
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
DK0725779T3 (da) Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner
HUT74992A (en) Use of serotonin antagonist indol derivatives for producing pharmaceutical compositions using for treating fibromyalgia
ES2181902T3 (es) Derivados de 4,5-diaril-oxazol.
ES2166470T3 (es) Derivados de indolalquilo de la benzodioxanmetilamina como ligandos de los receptores 5-ht1a.
ES2159017T3 (es) 2-aminoindanos como ligandos selectivos de la dopamina d3.
ES2159345T3 (es) Indazolcarboxamidas.
PH18686A (en) 1-(3 halo-2-pyridinyl) piperazine
ATE117980T1 (de) Serotonin-antagonisten.
ES2151993T3 (es) 1,2,3,4-tetrahidro-9h-carbazoles 6-sustituidos y 10h-ciclohepta(7,6-b)indoles 7-sustituidos.
ES2088661T3 (es) Bis-naftalimidas fuertemente solubles en agua utiles como agentes anti-cancerigenos.
IT1164387B (it) Derivati n-sostituiti dell'1-(4'-alchilsulfonilfenil)-2-ammino-1,3-propandiolo
ES2163765T3 (es) Mezclas fungicidas.
ES2054729T3 (es) Derivados de pirrolidina.
ES2167725T3 (es) Procedimiento para la coloracion de material organico de alto peso molecular, y pigmentos policiclicos.
CY1108050T1 (el) Η χρηση της μεκαμυλαμινης για τη θεραπεια των ανταποκρινομενων στη νικοτινη νευροψυχιατρικων διαταραχων
FI931188A (fi) Nya 17-b-estradiolderivater, foerfaranden foer deras framstaellning och laekemedel innehaollande dessa foereningar
ES2150564T3 (es) Proceso para la preparacion de derivados de 5,6-dihidroxi-2-amino-1,2,3,4-tetrahidronaftaleno.
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
ATE113949T1 (de) Alpha-adrenergische rezeptorantagonisten.
ATE56012T1 (de) Indolo-(6,5,4-cd)-indol derivate und verfahren zu deren herstellung.